Regulation of hepatic insulin-like growth factor I leader exonusage in lambs: effect of immunization against growth hormone-releasing factor and subsequent growth hormone treatment

2002 ◽  
Vol 80 (4) ◽  
pp. 1074-1082 ◽  
Author(s):  
D. C. O'Sullivan ◽  
T A M Szestak ◽  
J. M. Pell
Keyword(s):  
Growth Hormone ◽  
Growth Factor ◽  
Growth Hormone Treatment ◽  
Hormone Treatment ◽  
Insulin Like Growth Factor ◽  
Subsequent Growth ◽  
Growth Hormone Releasing Factor ◽  
Factor I ◽  
Growth Factor I

Growth Hormone-Releasing Factor Regulation by Somatostatin, Growth Hormone and Insulin-Like Growth Factor I in Fetal Rat Hypothalamic-Brain Stem Cell Cocultures

1993 ◽  
Vol 58 (6) ◽  
pp. 655-665 ◽  
Author(s):  
Gumersindo Fernández Vázquez ◽  
Luanda Cacicedo ◽  
Maria Teresa de los Frailes ◽  
Maira Jesús Lorenzo ◽  
Rosa Tolón ◽  
...  
Keyword(s):  
Growth Hormone ◽  
Stem Cell ◽  
Growth Factor ◽  
Brain Stem ◽  
Insulin Like Growth Factor ◽  
Growth Hormone Releasing Factor ◽  
Factor I ◽  
Fetal Rat ◽  
Growth Factor I

Characteristics of phorbol ester stimulated growth hormone release: inhibition by insulin-like growth factor I, somatostatin, and low calcium medium and comparison with growth hormone releasing factor

1987 ◽  
Vol 65 (11) ◽  
pp. 2302-2307 ◽  
Author(s):  
M. S. Sheppard ◽  
B. A. Eatock ◽  
R. M. Bala
Keyword(s):  
Growth Hormone ◽  
Growth Factor ◽  
Inositol Phosphate ◽  
Cell System ◽  
Channel Blockers ◽  
Insulin Like Growth Factor ◽  
Growth Hormone Releasing Factor ◽  
Factor I ◽  
Low Calcium ◽  
Growth Factor I

TPA (12-O-tetradecanoylphorbol 13-acetate) is one of a class of compounds known as tumor promoters which perturb the inositol phosphate pathway in a number of cells. We have used TPA in a dispersed rat adenohypophysial cell system to probe the characteristics of growth hormone (GH) release. In this system we have found that the cells release GH in response to low concentrations of TPA: the EC50 was 0.23 ± 0.05 nM (n = 6) and the maximal concentration was 5 nM. However, the maximal TPA-induced GH release was only 34 ± 5% (n = 7) of the GH released by maximal growth hormone releasing factor (GRF) suggesting TPA releases a subpool of stored GH. Both somatostatin and insulin-like growth factor I inhibit GH release stimulated by TPA to the same extent as that stimulated by GRF, showing that the normal inhibitory control mechanism of release is not altered. Incubation in a low calcium medium that totally blocks GRF-stimuiated GH release also inhibits TPA-stimulated GH release. The calcium channel blockers nifedipine and diltiazem both partly inhibit GRF- and TPA-stimulated GH release, showing some component of the calcium necessary for GH release arises from influx across the cell membrane.

Sign in / Sign up

Export Citation Format

Share Document